209 related articles for article (PubMed ID: 26017634)
21. Design and development of analogues of dimers of insulin-like peptide 3 B-chain as high-affinity antagonists of the RXFP2 receptor.
Shabanpoor F; Zhang S; Hughes RA; Hossain MA; Layfield S; Ferraro T; Bathgate RA; Separovic F; Wade JD
Biopolymers; 2011; 96(1):81-7. PubMed ID: 20560146
[TBL] [Abstract][Full Text] [Related]
22. Insulin-like peptide 3 (INSL3) is a major regulator of female reproductive physiology.
Ivell R; Anand-Ivell R
Hum Reprod Update; 2018 Nov; 24(6):639-651. PubMed ID: 30204868
[TBL] [Abstract][Full Text] [Related]
23. Physiology and evolution of the INSL3/RXFP2 hormone/receptor system in higher vertebrates.
Ivell R; Alhujaili W; Kohsaka T; Anand-Ivell R
Gen Comp Endocrinol; 2020 Dec; 299():113583. PubMed ID: 32800774
[TBL] [Abstract][Full Text] [Related]
24. Role of the intra-A-chain disulfide bond of insulin-like peptide 3 in binding and activation of its receptor, RXFP2.
Zhang S; Hughes RA; Bathgate RA; Shabanpoor F; Hossain MA; Lin F; van Lierop B; Robinson AJ; Wade JD
Peptides; 2010 Sep; 31(9):1730-6. PubMed ID: 20570702
[TBL] [Abstract][Full Text] [Related]
25. Relaxin and related peptides in male reproduction.
Agoulnik AI
Adv Exp Med Biol; 2007; 612():49-64. PubMed ID: 18161481
[TBL] [Abstract][Full Text] [Related]
26. INSL3 as a biomarker of Leydig cell functionality.
Ivell R; Wade JD; Anand-Ivell R
Biol Reprod; 2013 Jun; 88(6):147. PubMed ID: 23595905
[TBL] [Abstract][Full Text] [Related]
27. Expression patterns of DLK1 and INSL3 identify stages of Leydig cell differentiation during normal development and in testicular pathologies, including testicular cancer and Klinefelter syndrome.
Lottrup G; Nielsen JE; Maroun LL; Møller LM; Yassin M; Leffers H; Skakkebæk NE; Rajpert-De Meyts E
Hum Reprod; 2014 Aug; 29(8):1637-50. PubMed ID: 24908673
[TBL] [Abstract][Full Text] [Related]
28. Human testicular insulin-like factor 3: in relation to development, reproductive hormones and andrological disorders.
Bay K; Andersson AM
Int J Androl; 2011 Apr; 34(2):97-109. PubMed ID: 20550598
[TBL] [Abstract][Full Text] [Related]
29. A novel circulating hormone of testis origin in humans.
Foresta C; Bettella A; Vinanzi C; Dabrilli P; Meriggiola MC; Garolla A; Ferlin A
J Clin Endocrinol Metab; 2004 Dec; 89(12):5952-8. PubMed ID: 15579743
[TBL] [Abstract][Full Text] [Related]
30. Ovarian expression of insulin-like peptide 3 (INSL3) and its receptor (RXFP2) during development of bovine antral follicles and corpora lutea and measurement of circulating INSL3 levels during synchronized estrous cycles.
Satchell L; Glister C; Bleach EC; Glencross RG; Bicknell AB; Dai Y; Anand-Ivell R; Ivell R; Knight PG
Endocrinology; 2013 May; 154(5):1897-906. PubMed ID: 23546605
[TBL] [Abstract][Full Text] [Related]
31. Diverse functions of insulin-like 3 peptide.
Esteban-Lopez M; Agoulnik AI
J Endocrinol; 2020 Oct; 247(1):R1-R12. PubMed ID: 32813485
[TBL] [Abstract][Full Text] [Related]
32. Dynamics of INSL3 peptide expression in the rodent testis.
Anand-Ivell R; Heng K; Hafen B; Setchell B; Ivell R
Biol Reprod; 2009 Sep; 81(3):480-7. PubMed ID: 19420383
[TBL] [Abstract][Full Text] [Related]
33. Expression and Role of INSL3 in the Fetal Testis.
Ivell R; Mamsen LS; Andersen CY; Anand-Ivell R
Front Endocrinol (Lausanne); 2022; 13():868313. PubMed ID: 35464060
[TBL] [Abstract][Full Text] [Related]
34. Biological role and clinical significance of insulin-like peptide 3.
Ivell R; Anand-Ivell R
Curr Opin Endocrinol Diabetes Obes; 2011 Jun; 18(3):210-6. PubMed ID: 21415739
[TBL] [Abstract][Full Text] [Related]
35. The orphan nuclear receptor NR4A1 regulates insulin-like 3 gene transcription in Leydig cells.
Robert NM; Martin LJ; Tremblay JJ
Biol Reprod; 2006 Feb; 74(2):322-30. PubMed ID: 16237153
[TBL] [Abstract][Full Text] [Related]
36. Analysis of transcript and methylation levels of INSL3 and RXFP2 in undescended and descended dog testes suggested promising biomarkers associated with cryptorchidism.
Nowacka-Woszuk J; Krzeminska P; Nowak T; Gogulski M; Switonski M; Stachowiak M
Theriogenology; 2020 Nov; 157():483-489. PubMed ID: 32898823
[TBL] [Abstract][Full Text] [Related]
37. Characterization of the rat INSL3 receptor.
Scott DJ; Fu P; Shen PJ; Gundlach A; Layfield S; Riesewijk A; Tomiyama H; Hutson JM; Tregear GW; Bathgate RA
Ann N Y Acad Sci; 2005 May; 1041():13-6. PubMed ID: 15956681
[TBL] [Abstract][Full Text] [Related]
38. Distinct activation modes of the Relaxin Family Peptide Receptor 2 in response to insulin-like peptide 3 and relaxin.
Bruell S; Sethi A; Smith N; Scott DJ; Hossain MA; Wu QP; Guo ZY; Petrie EJ; Gooley PR; Bathgate RAD
Sci Rep; 2017 Jun; 7(1):3294. PubMed ID: 28607406
[TBL] [Abstract][Full Text] [Related]
39. Anti-Müllerian hormone, testosterone, and insulin-like peptide 3 as biomarkers of Sertoli and Leydig cell function during deslorelin-induced testicular downregulation in the dog.
Balogh O; Somoskői B; Kollár E; Kowalewski MP; Gram A; Reichler IM; Klein R; Kawate N; Mester L; Walter B; Müller L
Theriogenology; 2021 Nov; 175():100-110. PubMed ID: 34534687
[TBL] [Abstract][Full Text] [Related]
40. Cooperative binding of insulin-like Peptide 3 to a dimeric relaxin family peptide receptor 2.
Svendsen AM; Vrecl M; Ellis TM; Heding A; Kristensen JB; Wade JD; Bathgate RA; De Meyts P; Nøhr J
Endocrinology; 2008 Mar; 149(3):1113-20. PubMed ID: 18063691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
